University of Ioannina
Η επίδραση των μικρού μοριακού βάρους ηπαρινών, σε βιοχημικούς δείκτες της αγγειογένεσης και τον μηχανισμό της πήξης, σε ασθενείς με καρκίνο του παχέους εντέρου που υποβάλλονται σε θεραπευτική εκτομή
Abstract
dc:descriptionBACKGROUND: The vascular endothelial growth factor (VEGF-A) is a potent regulator of angiogenesis and most likely has a prognostic value in patients with colon cancer. In these patients, low molecular weight heparins (LMWH), are indicated for the perioperative thromoboprophylaxis.AIM OF THE STUDY: The main goal of the study was to evaluate the impact of the usage of different doses (3.500 IU vs. 4.500 IU) and/or different time periods (10 vs. 30 days) of a specific LMWH (tinzaparin), for perioperative thromboprophylaxis, upon the perioperative levels of serum VEGF, in colon cancer patients who underwent planned to have curative tumor resection (R0). MATERIALS & METHODS: 76 consecutive colon cancer patients were initially randomized and the results of 59, who conducted the four study groups, were finally analyzed. In groups I and II, the patients received 3.500 IU of tinzaparin once per day for 10 and 30 days accordingly. In groups III and IV, the patients received 4.500 IU of tinzaparin once per day for the same time-periods. Blood samples for the evaluation of serum VEGF levels and the activities of protein C, Antithrombin III (ATIII) and coagulation factor VIII (FVIII) were obtained at the following days: pre-op, 10th and 30th post-op day. Genetic analysis for thrombophilic gene mutations were performed by PCR. Statistical analysis of the results was done using repeated measurements in mixed desing ANOVA (SPSS v21, Inc. Chicago, Ill).RESULTS: With regard to the main study groups (group I to IV), all patients showed a constant increase in VEGF-A levels at the 10th post-op day, compared to the pre-op day. This increase was statistically significant in groups I, II and IV (p=0.008, p=0.017, p=0.000 accordingly). Patients of groups I and II (short duration thromboprophylaxis) showed increased serum VEGF-A levels at 30th post-op day, compared to that of patients with extended duration thromboprophylaxis (groups II and IV - p=0.000). This result was mainly due to the effect of group IV in which the serum VEGF levels at the 30th post-op day were comparable to the pre-op levels. Additionally, the higher dose of tinzaparin administered for the extended period, was the most effective in regulating the coagulation cascade. This regulation was achieved through a better regulation of fluctuation of the activity levels of proteins C, ATIII, FVIII.CONCLUSIONS: In colon cancer patients the perioperative thromboprophylaxis with LMWH 4.500 IU for 30 days results in regulation of the variations of serum VEGF levels during the post operative period. At the 30th post-op day these levels are similar to that preoperatively. Simultaneously this thromboprophylaxis scheme regulates more effectively the coagulation cascade proteins.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koliou, Panagiotis
- Κολιού, Παναγιώτης
Subjects
dc:subject × 16- Καρκίνος παχέος εντέρου
- Ηπαρίνες μικρού μοριακού βάρους
- Αγγειογένεση
- Μηχανισμός πήξης
- Colon cancer
- Low molecular weight heparin (LMWH)
- Angiogenesis
- Coagulation pathway
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Clinical Medicine
Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38317